Skip to main content

. 1975 Feb 1;1(5952):268–269. doi: 10.1136/bmj.1.5952.268-d

Letter: Mithramycin for hypercalcaemia associated with myeloma and other malignancies.

I E Smith, T J Powles

PMCID: PMC1672059 PMID: 122909

268

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Harrington G., Olson K. B., Horton J., Cunningham T., Wright A. Neoplasia, hypercalcemia and mithramycin. N Engl J Med. 1970 Nov 19;283(21):1172–1172. doi: 10.1056/NEJM197011192832124. [DOI] [PubMed] [Google Scholar]
Monto R. W., Talley R. W., Caldwell M. J., Levin W. C., Guest M. M. Observations on the mechanism of hemorrhagic toxicity in mithramycin (NSC 24559) therapy. Cancer Res. 1969 Mar;29(3):697–704. [PubMed] [Google Scholar]
Perlia C. P., Gubisch N. J., Wolter J., Edelberg D., Dederick M. M., Taylor S. G., 3rd Mithramycin treatment of hypercalcemia. Cancer. 1970 Feb;25(2):389–394. doi: 10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES